Gordon Blair
Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2)
Blair, Gordon; Appleton, Jason P.; Doubal, Fergus N.; Mhlanga, Iris I.; Woodhouse, Lisa J.; Bath, Philip M.; Wardlaw, Joanna M.
Authors
Jason P. Appleton
Fergus N. Doubal
IRIS MHLANGA IRIS.MHLANGA@NOTTINGHAM.AC.UK
Research Assistant
Dr LISA WOODHOUSE L.Woodhouse@nottingham.ac.uk
Research Fellow
PHILIP BATH philip.bath@nottingham.ac.uk
Stroke Association Professor of Stroke Medicine
Joanna M. Wardlaw
Abstract
Cerebral small vessel disease (cSVD) causes lacunar stroke (25% of ischaemic strokes), haemorrhage, dementia, physical frailty, or is 'covert', but has no specific treatment. Uncertainties about the design of clinical trials in cSVD, which patients to include or outcomes to assess, may have delayed progress. Based on experience in recent cSVD trials, we reviewed ways to facilitate future trials in patients with cSVD. We assessed the literature and the LACunar Intervention Trial 2 (LACI-2) for data to inform choice of Participant, Intervention, Comparator, Outcome, including clinical versus intermediary endpoints, potential interventions, effect of outcome on missing data, methods to aid retention and reduce data loss. We modelled risk of missing outcomes by baseline prognostic variables in LACI-2 using binary logistic regression. Imaging versus clinical outcomes led to larger proportions of missing data. We present reasons for and against broad versus narrow entry criteria. We identified numerous repurposable drugs with relevant modes of action to test in various cSVD subtypes. Cognitive impairment is the most common clinical outcome after lacunar ischaemic stroke but was missing more frequently than dependency, quality of life or vascular events in LACI-2. Assessing cognitive status using Diagnostic and Statistical Manual for Mental Disorders Fifth Edition can use cognitive data from multiple sources and may help reduce data losses. Trials in patients with all cSVD subtypes are urgently needed and should use broad entry criteria and clinical outcomes and focus on ways to maximise collection of cognitive outcomes to avoid missing data.
Citation
Blair, G., Appleton, J. P., Doubal, F. N., Mhlanga, I. I., Woodhouse, L. J., Bath, P. M., & Wardlaw, J. M. (2024). Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2). Stroke and Vascular Neurology, https://doi.org/10.1136/svn-2023-003022
Journal Article Type | Review |
---|---|
Acceptance Date | Mar 2, 2024 |
Online Publication Date | Apr 3, 2024 |
Publication Date | Apr 3, 2024 |
Deposit Date | Mar 4, 2024 |
Publicly Available Date | Apr 3, 2024 |
Journal | Stroke and Vascular Neurology |
Electronic ISSN | 2059-8696 |
Publisher | BMJ Publishing Group |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1136/svn-2023-003022 |
Keywords | stroke, small vessel disease, lacunar stroke, clinical trial |
Public URL | https://nottingham-repository.worktribe.com/output/32162597 |
Files
svn-2023-003022.full
(896 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
Copyright Statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ
Design of trials in lacunar stroke
(86 Kb)
PDF
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search